Form 4 for OPRX OptimizeRx Corp
Accepted 2021-08-24 00:00:00 ET · period of report 2021-08-20 · accession 0001213900-21-044609 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-24 | 2021-08-20+ | OPRX | BAKER DOUGLAS P | CFO | S - Sale | $59.81 | -9,000 | 54.8K | -14% | -$538.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-08-20 | S | D | 5,000 | $58.45 | 58,796 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-08-24 | S | D | 4,000 | $61.50 | 54,796 | D | — | — | (F2) These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |